Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection

被引:4
|
作者
Altieri, Barbara [1 ]
La Salvia, Anna [2 ]
Modica, Roberta [3 ]
Marciello, Francesca [3 ]
Mercier, Olaf [4 ]
Filosso, Pier Luigi [5 ]
de Latour, Bertrand Richard [6 ]
Giuffrida, Dario [7 ]
Campione, Severo [8 ]
Guggino, Gianluca [9 ]
Fadel, Elie [4 ]
Papotti, Mauro [10 ]
Colao, Annamaria [3 ]
Scoazec, Jean-Yves [11 ]
Baudin, Eric [12 ]
Faggiano, Antongiulio [13 ]
机构
[1] Univ Wurzburg, Univ Hosp, Dept Internal Med1, Div Endocrinol & Diabet, D-97080 Wurzburg, Germany
[2] Natl Inst Hlth ISS, Natl Ctr Drug Res & Evaluat, I-00161 Rome, Italy
[3] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy
[4] Univ Paris Saclay, Marie Lannelongue Hosp, Dept Thorac Surg & Heart & Lung Transplantat, GHPSJ, F-92350 Le Plessis Robinson, France
[5] Univ Turin, San Giovanni Battista Hosp, Dept Thorac Surg, I-10126 Turin, Italy
[6] Univ Rennes, Univ Hosp Rennes Pontchaillou, Dept Thorac & Cardiovasc Surg, Rennes, France
[7] Mediterranean Inst Oncol, Dept Expt Oncol, Clin Oncol Unit, I-95029 Catania, Italy
[8] Cardarelli Hosp, Dept Adv Technol, Pathol Unit, I-80131 Naples, Italy
[9] Cardarelli Hosp, Dept Thorac Surg, I-80131 Naples, Italy
[10] Univ Turin, Dept Oncol, Pathol Unit, I-10126 Turin, Italy
[11] Univ Paris Saclay, Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
[12] Paris Saclay Univ, Inst Gustave Roussy, Endocrine Oncol & Nucl Med Dept, F-94805 Villejuif, Paris, France
[13] Sapienza Univ Rome, Sant Andrea Hosp, Dept Clin & Mol Med, Endocrinol Unit, I-00189 Rome, Italy
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 02期
关键词
neuroendocrine tumor; LCNEC; pulmonary cancer; prognostic marker; prognosis; survival; lymph nodes; age; surgery; adjuvant therapy; CLASSIFICATION; EPIDEMIOLOGY; OUTCOMES; SURGERY; CANCER;
D O I
10.3390/jpm13020330
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Large Cell Neuroendocrine Carcinoma (LCNEC) is a rare subtype of lung cancer with poor clinical outcomes. Data on recurrence-free survival (RFS) in early and locally advanced pure LCNEC after complete resection (R0) are lacking. This study aims to evaluate clinical outcomes in this subgroup of patients and to identify potential prognostic markers. Methods: Retrospective multicenter study including patients with pure LCNEC stage I-III and R0 resection. Clinicopathological characteristics, RFS, and disease-specific survival (DSS) were evaluated. Univariate and multivariate analyses were performed. Results: 39 patients (M:F = 26:13), with a median age of 64 years (44-83), were included. Lobectomy (69.2%), bilobectomy (5.1%), pneumonectomy (18%), and wedge resection (7.7%) were performed mostly associated with lymphadenectomy. Adjuvant therapy included platinum-based chemotherapy and/or radiotherapy in 58.9% of cases. After a median follow-up of 44 (4-169) months, the median RFS was 39 months with 1-, 2- and 5-year RFS rates of 60.0%, 54.6%, and 44.9%, respectively. Median DSS was 72 months with a 1-, 2- and 5-year rate of 86.8, 75.9, and 57.4%, respectively. At multivariate analysis, age (cut-off 65 years old) and pN status were independent prognostic factors for both RFS (HR = 4.19, 95%CI = 1.46-12.07, p = 0.008 and HR = 13.56, 95%CI 2.45-74.89, p = 0.003, respectively) and DSS (HR = 9.30, 95%CI 2.23-38.83, p = 0.002 and HR = 11.88, 95%CI 2.28-61.84, p = 0.003, respectively). Conclusion: After R0 resection of LCNEC, half of the patients recurred mostly within the first two years of follow-up. Age and lymph node metastasis could help to stratify patients for adjuvant therapy.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Contrast-enhanced CT radiomics for prediction of recurrence-free survival in gallbladder carcinoma after surgical resection
    Xiang, Fei
    Liang, Xiaoyuan
    Yang, Lili
    Liu, Xingyu
    Yan, Sheng
    EUROPEAN RADIOLOGY, 2022, 32 (10) : 7087 - 7097
  • [32] The survival benefit from surgery on patients with large-cell neuroendocrine carcinoma in the lung: a propensity-score matching study
    Jiang, Hao
    Xie, Weixia
    Li, Xianpeng
    Wang, Huaying
    Yu, Wan-Jun
    Chen, Xiaolu
    JOURNAL OF CARDIOTHORACIC SURGERY, 2023, 18 (01)
  • [33] Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer
    Taylor, Matthew D.
    Nagji, Alykhan S.
    Bhamidipati, Castigliano M.
    Theodosakis, Nicholas
    Kozower, Benjamin D.
    Lau, Christine L.
    Jones, David R.
    ANNALS OF THORACIC SURGERY, 2012, 93 (06) : 1813 - 1821
  • [34] Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
    Hwang, Eu Chang
    Hwang, Insang
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    Heo, Suk Hee
    Hwang, Jun Eul
    Kang, Sung Gu
    Kang, Seok Ho
    Lee, Jeong Gu
    Kim, Je Jong
    Cheon, Jun
    BMC UROLOGY, 2014, 14
  • [35] Bronchial Stump Recurrence after Complete Resection of Lung Cancer: Effect of the Distance between the Tumor and Bronchial Resection Margin
    Gunluoglu, Mehmet Zeki
    Kocaturk, Celalettin Ibrahim
    Demir, Adalet
    Urer, Halide Nur
    Dincer, Seyyit Ibrahim
    Bedirhan, Mehmet Ali
    THORACIC AND CARDIOVASCULAR SURGEON, 2018, 66 (02) : 156 - 163
  • [36] Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer
    Brown, Lisa M.
    Louie, Brian E.
    Jackson, Nicole
    Farivar, Alexander S.
    Aye, Ralph W.
    Vallieres, Eric
    ANNALS OF THORACIC SURGERY, 2016, 102 (04) : 1110 - 1118
  • [37] Macroscopic Type Is a Prognostic Factor for Recurrence-free Survival After Resection of Gastric GIST
    Miyamoto, Hiroshi
    Kunisaki, Chikara
    Otsuka, Yuichi
    Takahashi, Masazumi
    Takagawa, Ryo
    Misuta, Koichiro
    Kameda, Kunio
    Makino, Hirochika
    Matsuda, Goro
    Yamaguchi, Naotaka
    Kamiya, Noriyuki
    Murakami, Takashi
    Morita, Satoshi
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2014, 34 (08) : 4267 - 4273
  • [38] Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection
    Jeong Won Lee
    Sang Hyun Hwang
    Hyun Jeong Kim
    Dongwoo Kim
    Arthur Cho
    Mijin Yun
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1984 - 1994
  • [39] Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?
    Jiang, Liyang
    Meng, Xiangjiao
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (01) : 44 - 50
  • [40] Long-term Survival of Advanced Small Cell Carcinoma of the Esophagus after Resection: A Case Report
    Muguruma, Kazuya
    Ohira, Masaichi
    Tanaka, Hiroaki
    Kubo, Naoshi
    Yamashita, Yoshito
    Sawada, Tetsuji
    Wakasa, Kenichi
    Hirakawa, Kosei
    ANTICANCER RESEARCH, 2013, 33 (02) : 595 - 600